Comparison of donor-site morbidity and functional outcomes between lateral iliac crest–preserving iliac bone harvesting and conventional iliac bone harvesting: a retrospective case–control study Authors: Minhua Hu, Weifeng Liang, Jiayi Chen, Feifan Luan, Guangwen Yu, Chunwei Wei, Zhisen Wu, Chenxiao Zheng, Zhuneng Guo Published: 2026 ABSTRACT AbstractBackgroundThe iliac crest is the most frequently used donor site for harvesting autologous corticocancellous bone grafts. However, the reported incidence of donor-site morbidity after autologous corticocancellous iliac crest bone graft harvesting varies widely, potentially owing to differences in harvesting techniques. This study describes a lateral iliac crest–preserving iliac crest bone graft harvesting (LICP-ICBG) technique for obtaining autologous corticocancellous bone grafts and compares donor-site complications and functional outcomes with those of conventional corticocancellous iliac crest bone graft harvesting (CLCH).MethodsIn this study, 101 patients were included and classified according to the harvesting technique: LICP-ICBG (n = 50) and CLCH (n = 51). Intraoperative blood loss and donor-site complications were recorded. Postoperative pain was assessed using a visual analog scale (VAS) on postoperative days 1, 3, and 7. Functional impairment was evaluated using a questionnaire focusing on gait, stair climbing, and difficulty rising from a seated position. Donor-site healing was assessed on pelvic radiographs.ResultsIntraoperative blood loss was lower in the LICP-ICBG group than in the CLCH group. Donor-site complications occurred in 10% (5/50) of patients in the LICP-ICBG group, including incisional hematoma/seroma in 4% (2/50), donor-site infection in 4% (2/50), and residual pain in 2% (1/50). In the CLCH group, complications occurred in 25.5% (13/51), including incisional hematoma/seroma in 9.8% (5/51), donor-site infection in 3.92% (2/51), nerve injury in 3.92% (2/51), residual pain in 3.92% (2/51), and iliac crest contour depression in 3.92% (2/51), with a significant between-group difference (p < 0.05). VAS pain scores on postoperative days 1, 3, and 7 and patient-reported satisfaction regarding gait, stair climbing, and hip function during daily activities did not differ significantly between groups (all p > 0.05). For rising from a seated position, 2% (1/50) of patients in the LICP-ICBG group were somewhat dissatisfied, whereas in the CLCH group 11.8% (6/51) were somewhat dissatisfied and 3.9% (2/51) were very dissatisfied (p = 0.02).ConclusionsCompared with CLCH, the LICP-ICBG technique was associated with lower intraoperative blood loss and a lower rate of donor-site complications, particularly fewer nerve injuries and iliac crest contour depressions. Although postoperative pain and most functional outcomes were comparable, patients reported better performance when rising from a seated position. Radiographic follow-up suggested improved preservation of iliac wing contour and more favorable donor-site healing. This modified technique may help reduce donor-site morbidity and preserve the iliac crest contour while providing sufficient autologous corticocancellous bone graft material.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12891-026-10090-x.Keywords: Morbidity, Lateral iliac crest–preserving iliac bone harvesting, Conventional iliac bone harvesting, Functional outcomes Introduction Autologous bone grafting has long been widely used in orthopedic trauma and reconstruction. Despite the rapid development of bone substitute technologies in recent years, including allografts, biomaterial scaffolds, growth factors, and stem cells as alternative or adjunctive options, autologous bone grafts remain the gold standard for bone defect repair due to their osteoinductive and osteoconductive properties, excellent biocompatibility, and lack of immunogenicity [1]. The iliac crest, owing to its superficial anatomical location, ease of access, and the ability to provide both cortical and cancellous bone, is the most commonly used donor site for bone grafting [2]. However, the incidence of donor-site morbidity after iliac crest harvest varies widely, likely due to differences in harvesting site, technique, and patient population. Common complications include persistent or chronic donor-site pain, incisional hematoma/seroma, infection, nerve injury and numbness, iliac crest contour depression, and donor-site hernia, all of which can significantly impact the patient’s quality of life [3, 4]. Therefore, optimizing the iliac crest harvesting technique to reduce donor-site morbidity and improve postoperative functional outcomes remains a critical clinical challenge. Iliac crest harvesting for autologous corticocancellous bone grafting is typically performed through the anterior or posterior iliac crest. Previous studies suggest that the overall complication rates between these two sites may be similar, although the specific complication profiles differ. Compared to the posterior iliac crest, anterior iliac crest harvesting may be associated with a higher incidence of infection, hematoma formation, fractures, and pigmented scar formation, while the incidence of chronic donor-site pain and sensory disturbances may be relatively lower [5]. Furthermore, a variety of iliac crest harvesting techniques have been developed clinically, including minimally invasive iliac crest harvesting using an iliac crest ring drill, open “U” shaped harvesting for full iliac crest bone plate, iliac wing harvesting via “H”-shaped osteotomy, open harvesting for the iliac crest inner plate, and lateral iliac crest preservation with rectangular bone block harvest [6–9]. However, each technique has its limitations, and donor-site pain, contour changes, and abdominal wall-related complications (such as donor-site hernia) remain insufficiently controlled. In light of these challenges, this study aimed to introduce a lateral iliac crest–preserving iliac crest bone graft harvesting (LICP-ICBG) technique for obtaining autologous corticocancellous iliac crest bone grafts for local grafting in cases of extremity long-bone shaft nonunion, including nonunion of the humerus, tibia, femur, ulna, or radius. Through a retrospective case–control study, we compared this technique with conventional iliac crest harvesting for autologous corticocancellous bone grafting (CLCH) in terms of donor-site complications and functional outcomes to analyze the clinical characteristics and potential advantages of the lateral iliac crest–preserving technique. The goal was to provide evidence to reduce donor-site morbidity and to guide the selection of harvesting techniques. Materials and methods Patients This retrospective case-control study was conducted at our hospital between March 2019 and April 2024. Patients who underwent iliac crest harvesting for autologous corticocancellous bone grafting using the LICP-ICBG technique were evaluated and compared with those who underwent CLCH. The choice of LICP-ICBG versus CLCH was based on the treating surgeon’s clinical judgment and surgical experience rather than random allocation. This study was performed in accordance with the Declaration of Helsinki, and approval was obtained from the Institutional Review Board of Zhongshan Hospital of Traditional Chinese Medicine. Eligibility criteria Eligible patients were those aged 18–70 years who underwent autogenous bone grafting for the treatment of nonunion of an extremity long-bone shaft, including the humeral, tibial, femoral, ulnar, or radial shaft. Patients were excluded if they met any of the following criteria: a history of previous iliac crest bone grafting; the presence of bilateral iliac wing fracture or deformities; diagnosis of malignant tumor or rheumatoid arthritis; or local infection at the donor site. Moreover, patients with high surgical risk, contraindications to anesthesia, those with incomplete clinical data or incomplete follow-up were also excluded. Surgical technique and postoperative management LICP-ICBG technique Exposure of the donor site Following the induction of general anesthesia, the patient was placed in the supine position. A skin incision approximately 5 cm in length was made along the medial border of the iliac crest, starting about 2 cm posterior to the anterior superior iliac spine (ASIS) (Fig. 1A). The iliac crest was exposed, and the periosteum together with the muscular attachments of the abdominal muscles, was incised along the midline of the iliac crest. Care was taken to preserve the periosteum on the lateral aspect of the iliac crest. Subperiosteal dissection was then performed along the inner table of the ilium, staying medial to the iliac crest. A Hohmann retractor was used to retract the abdominal muscles and iliopsoas muscles medially and distally, thereby adequately exposing the inner table of the ilium. Intraoperative photographs of the LICP-ICBG procedure. A Skin incision. B–C Harvested corticocancellous bone graft Harvesting of the bone graft An autologous corticocancellous iliac crest bone graft was harvested from the iliac crest and inner table. ① First osteotomy: Starting at a point approximately 2 cm posterior to the ASIS and on the central axis of the iliac crest, a sharp, thin osteotome was used to perform the first cut. The osteotome was oriented parallel to the iliac crest and angled approximately 45° outward and backward relative to the plane of the ilium. This cut penetrated the outer cortex, extending 5–7 cm, typically passing beyond the gluteal pillar. The length was adjusted according to the required graft volume (Fig. 2A). ① First osteotomy: Starting at a point approximately 2 cm posterior to the ASIS and on the central axis of the iliac crest, a sharp, thin osteotome was used to perform the first cut. The osteotome was oriented parallel to the iliac crest and angled approximately 45° outward and backward relative to the plane of the ilium. This cut penetrated the outer cortex, extending 5–7 cm, typically passing beyond the gluteal pillar. The length was adjusted according to the required graft volume (Fig. 2A). ② Second osteotomy: Beginning at the anterior end of the first osteotomy, a second cut was made at an angle of 90° or 120° to the first cut line. This osteotomy, perpendicular to the iliac wing, penetrated both the inner and outer cortices for a length of 5–7 cm (Fig. 2B). ② Second osteotomy: Beginning at the anterior end of the first osteotomy, a second cut was made at an angle of 90° or 120° to the first cut line. This osteotomy, perpendicular to the iliac wing, penetrated both the inner and outer cortices for a length of 5–7 cm (Fig. 2B). ③ Third osteotomy: At the posterior endpoint of the first osteotomy, a third cut was made parallel to and equal in length to the second osteotomy, also perpendicular to the iliac wing, penetrating both cortices (Fig. 2C). ③ Third osteotomy: At the posterior endpoint of the first osteotomy, a third cut was made parallel to and equal in length to the second osteotomy, also perpendicular to the iliac wing, penetrating both cortices (Fig. 2C). ④ Completion of the osteotomy: Finally, a connecting cut was made between the distal endpoints of the second and third osteotomies. The handle of the osteotome was depressed firmly to orient the blade as perpendicularly as possible to the iliac wing, thereby penetrating both cortices and detaching the target corticocancellous bone graft from the main iliac wing (Fig. 2D). ④ Completion of the osteotomy: Finally, a connecting cut was made between the distal endpoints of the second and third osteotomies. The handle of the osteotome was depressed firmly to orient the blade as perpendicularly as possible to the iliac wing, thereby penetrating both cortices and detaching the target corticocancellous bone graft from the main iliac wing (Fig. 2D). Surgical steps of the LICP-ICBG technique. A The first osteotomy is made parallel to the iliac crest along the midline of its longitudinal axis. B The second osteotomy is performed at the anterior end of the first cut, perpendicular to the iliac wing, penetrating both the inner and outer cortices. C The third osteotomy is made at the posterior end of the first cut, parallel to and equal in length to the second cut, and perpendicular to the iliac wing, penetrating both cortices. D The osteotome handle is levered downward to detach the targeted autologous corticocancellous iliac crest bone graft. E Pelvic appearance after completion of osteotomy. F–H The harvested autologous corticocancellous iliac crest bone graft after osteotomy After the osteotomies were completed, the osteotome was inserted into the middle superior portion of the second osteotomy line. Using the robust anterior bone column containing the anterior superior and inferior iliac spines as a fulcrum, the target corticocancellous bone graft was gently levered medially and distally. A rongeur was then used to grasp the anteroproximal corner of the graft, and the graft was gently rotated medially and distally. Concurrently, the osteotome was used for subperiosteal dissection along the outer table to detach the graft from the gluteal muscles, allowing complete removal of the graft (Fig. 1B, C). Wound closure The surgical site was copiously irrigated with sterile normal saline. Hemostasis was achieved meticulously using electrocautery. Bone wax was not applied to the raw surface of the iliac donor site. To eliminate dead space, a single layer of absorbable gelatin sponge was placed flat within the bone window. A suction drain was placed if deemed necessary. The muscular attachments were re-approximated and secured to the lateral iliac crest using interrupted figure-of-eight sutures with 1 − 0 absorbable suture. The subcutaneous tissue was closed with 2 − 0 absorbable suture in a continuous layer, and the skin was closed with interrupted silk sutures. CLCH technique After general anesthesia was induced, the surgical field was prepared and draped in a standard sterile fashion. A skin incision was made approximately 2 cm posterior to the ASIS. The length of the incision was determined based on the estimated graft volume required. Sequential dissection was carried through the skin, subcutaneous tissue, and fascia to expose the iliac crest. The periosteum over both the inner and outer tables of the ilium was elevated and stripped, typically using a periosteal elevator in combination with a gauze swab for blunt dissection. Subsequently, an osteotome was used to perform the first vertical osteotomy approximately 2 cm posterior to the ASIS. A second vertical osteotomy was then made at an appropriate distance from the first, as needed. Finally, a third transverse osteotomy was performed at a predetermined distance from the iliac crest, depending on the required graft volume. These three osteotomies resulted in a free autologous corticocancellous iliac crest bone graft, which was then harvested. The harvested autologous corticocancellous iliac crest bone graft was trimmed as necessary for subsequent implantation. The donor site was copiously irrigated, and hemostasis was achieved using electrocautery. The fascial layer over the remaining iliac crest was re-approximated and sutured. The wound was closed in layers. Postoperative management As part of the routine perioperative management practice in our department during the study period, prophylactic antibiotics were administered for 24 to 72 h postoperatively. Beginning on the first postoperative day, patients were instructed to perform hip and knee flexion exercises along with sitting up. Depending on the functional rehabilitation requirements of the primary fracture site, protected ambulation with the aid of crutches was initiated between postoperative days 3 and 7. The incision at the iliac bone graft donor site was routinely inspected and dressed. Sutures were removed at 2 weeks postoperatively, after which the wound was left uncovered without further bandaging. Outcome measures We compared intraoperative blood loss between the two bone-harvesting techniques and recorded postoperative donor-site complications, including incisional hematoma/seroma, donor-site infection, nerve injury, numbness, iliac crest depression, donor-site hernia, and sensory disturbance. Donor-site complications were retrospectively assessed by the study investigators based on postoperative medical records, follow-up documentation, and available pelvic radiographs. Because the surgical technique could be identified from the operative records and postoperative imaging, the assessors were not blinded to the surgical technique. Intraoperative blood loss was estimated by measuring the volume in the suction canister after subtracting the irrigation fluid volume and by estimating the amount of blood absorbed by surgical gauze and sponges. Postoperative donor-site pain was assessed using the visual analog scale on postoperative days 1, 3, and 7. For categorical analyses, VAS scores were stratified into three levels: 0–2 (no pain), > 2–6 (tolerable pain), and > 6–10 (intolerable pain). Pain and sensory disturbance were classified as transient when they lasted for less than 6 months and as residual when they persisted for 6 months or longer. Accordingly, residual pain was defined as donor-site pain persisting for at least 6 months after surgery. Nerve injury was defined as a newly documented postoperative neurologic deficit attributable to the iliac crest donor site. Residual sensory disturbance was defined as persistent abnormal sensation, including numbness, hypoesthesia, or paresthesia, in the donor-site region for at least 6 months after surgery without a formally documented nerve injury. Iliac crest depression was defined as a clinically evident postoperative contour deformity at the donor site, supported by postoperative radiographic assessment when available. Donor-site healing was evaluated on pelvic radiographs. Functional outcomes related to the iliac crest donor site were assessed at the 12-month postoperative follow-up using an investigator-designed questionnaire, which is provided in Supplementary Material 1. This questionnaire consisted of two parts. Part I evaluated donor-site–related functional impairment using dichotomous “Yes/No” items, including gait abnormality or limitation, difficulty climbing stairs, difficulty rising from a seated position, limitation or discomfort in donor-side hip function during daily activities, and other donor-site–related functional impairment. Part II assessed overall satisfaction with donor-site functional recovery using three response categories: “satisfied,” “somewhat dissatisfied,” and “very dissatisfied.” Statistical analysis Continuous variables were examined for normality and are presented as mean ± standard deviation or median with interquartile range [M (P25, P75)], as appropriate. For non-normally distributed continuous variables, between-group comparisons were performed using the Wilcoxon rank-sum test. Categorical variables were compared using the Pearson chi-square test or Fisher’s exact test, as appropriate. A two-sided P value < 0.05 was considered statistically significant. Results A total of 101 patients met the inclusion criteria and were included in the analysis. All included patients completed 12 months of follow-up. Fifty patients underwent corticocancellous iliac crest bone graft harvesting using the LICP-ICBG technique, including 27 men (54.0%) and 23 women (46.0%), and 51 patients underwent CLCH, including 24 men (47.1%) and 27 women (52.9%). Baseline characteristics of the two groups are summarized in Table 1. The mean age was 39.88 ± 14.03 years in the LICP-ICBG group and 44.19 ± 12.44 years in the CLCH group. No statistically significant differences were observed between the groups in sex, age, BMI, smoking status, diabetes mellitus, or graft recipient site (P > 0.05). Table 1Demographic and clinical characteristics of LICP-ICBG and CLCH groupsCharacteristicsLateral iliac crest–preserving iliac crest bone graft harvesting technique Group(n = 50)Conventional iliac crest bone graft harvesting technique Group(n = 51)P valueGender(%)0.485 Male27(54.0%)24(47.05%) Female23(46.0%)27(52.95%)Age(years)(x ± s)39.88 ± 14.0344.19 ± 12.440.105Bone non-union(%)0.839 Femur14(28%)16(31.4%) Radius3(6.0%)5(9.8%) Ulna1(2.0%)1(2.0%) Tibia20(40.0%)15(29.4%) Humerus12(24.0%)14(27.5%)Diabetes mellitus (%)6(12.0%)3(5.9%)0.466 Smoking (%)8(16.0%)10(19.6%)0.636 BMI ( kg/m²)22.22 ± 3.0121.87 ± 2.710.537 Demographic and clinical characteristics of LICP-ICBG and CLCH groups Median intraoperative blood loss was 69 (56, 87.5) mL in the LICP-ICBG group and 92 (78,102) mL in the CLCH group, with a statistically significant between-group difference (P < 0.001). During postoperative follow-up, 5 patients (10.0%) in the LICP-ICBG group developed donor-site complications, including 2 cases (4.0%) of incisional hematoma/seroma, 2 cases (4.0%) of donor-site infection, and 1 case (2.0%) of residual pain. No cases of nerve injury, numbness, iliac crest depression, donor-site hernia, or sensory disturbance were observed in this group. In the CLCH group, 13 patients (25.5%) experienced donor-site complications, including 5 cases (9.8%) of incisional hematoma/seroma, 2 cases (3.92%) of donor-site infection, 2 cases (3.92%) of nerve injury, 2 cases (3.92%) of residual pain, and 2 cases (3.92%) of iliac crest depression. No donor-site hernia or residual sensory disturbance was observed. The overall complication rate differed significantly between groups (P < 0.05) (Table 2). No patient experienced multiple complications in this series. Table 2Comparison of blood loss and complication rates between the two groupsIndicesLateral iliac crest–preserving iliac crest bone graft harvesting technique Group(n = 50)Conventional iliac crest bone graft harvesting technique Group(n = 51)P valueBlood loss(ml) M(P25, P75)69 (56, 87.5)92 (78, 102)0.001Complication (n)(%)5 (10.0%)13 (25.5%)0.042 Hematoma (n)(%)2 (4%)5 (9.8%) Infection (n)(%)2 (4%)2 (3.92%) Nerve injury (n)(%)02 (3.92%) Iliac crest depression (n)(%)02 (3.92%) Donor-site hernia (n)(%)00 Residual sensory disturbance (n)(%)00 Residual pain (n)(%)1(2%)2(3.92%) Comparison of blood loss and complication rates between the two groups Among the 101 patients who completed the postoperative pain questionnaire, there were no significant between-group differences in pain tolerance on postoperative days 1, 3, and 7 (P > 0.05). With respect to function, patient-reported satisfaction regarding gait, stair climbing, and hip function did not differ between the groups (P > 0.05). However, dissatisfaction with rising from a seated position was less frequent in the LICP-ICBG group: 1 patient (2.0%) reported being “somewhat dissatisfied,” whereas in the CLCH group, 6 patients (11.8%) were “somewhat dissatisfied” and 2 patients reported being “very dissatisfied” (P = 0.02) (Table 3). Table 3Questionnaire-based postoperative pain and functional outcomes in the two groupsQuestionnaireLateral iliac crest–preserving iliac crest bone graft harvesting technique Group(n = 50)Conventional iliac crest bone graft harvesting technique Group(n = 51)P valueVAS(postoperative)PainlessTolerable painUnbearable painPainlessTolerable painUnbearable painDAY 1042(84%)8(16%)041(80.4%)10(19.6%)0.636DAY 34(8%)41(82%)5(10%)2(3.92%)42(82.35%)7(13.73%)0.679DAY 716(32%)33(66%)1(2%)9(17.6%)41(80.45%)1(2%)0.18Dysfunctionsatisfiedsomewhat dissatisfiedvery dissatisfiedsatisfiedsomewhat dissatisfiedvery dissatisfiedGait49(98%)1(2%)049(96.1%)2(3.9%)01Climbing stairs48(96%)2(4%)046(90.2%)4(7.8%)1(2%)0.35Stand up in a seated position49(98%)1(2%)043(84.3%)6(11.8%)2(3.9%)0.02Hip function50(100%)0051(100%)001 Questionnaire-based postoperative pain and functional outcomes in the two groups In the LICP-ICBG group, radiographic evaluation at 3 months showed osseous union at the osteotomy site between the preserved lateral iliac crest and the remaining ilium in all patients. At 6 months, the donor-site defect area had decreased. In contrast, the donor-site defect area did not decrease in the CLCH group. The contour of the iliac wing remained intact in the LICP-ICBG group, and no donor-site discomfort was reported during follow-up (Fig. 3). Conversely, radiographs in the CLCH group showed an incomplete iliac wing contour with a concave deformity, and some patients reported persistent discomfort (Fig. 4). Radiographic findings in the LICP-ICBG group. At 3 months postoperatively (B, E), union between the preserved iliac crest and the ilium was observed. At 6 months (C, F), the donor-site defect area had decreased, and the iliac wing contour remained normal without a concave deformity. A–C Patient 1: female, 40 years old, left-sided LICP-ICBG. D–F Patient 2: male, 52 years old, right-sided LICP-ICBG Pelvic anteroposterior radiographs of a 45-year-old male patient who underwent CLCH (non–iliac contour–preserving harvesting). At 6 months postoperatively, a marked concave deformity at the donor site was evident. A Preoperative radiograph. B 3 months postoperatively. C 6 months postoperatively Discussion This study compared the LICP-ICBG and CLCH with respect to donor-site morbidity and functional outcomes. Our main findings were as follows: (1) intraoperative blood loss was lower in the LICP-ICBG group; (2) the overall donor-site complication rate was significantly reduced with LICP-ICBG (10.0% vs. 25.5%); (3) although early postoperative pain tolerance did not differ between the groups, difficulty rising from a seated position was less frequently reported in the LICP-ICBG group; and (4) radiographic follow-up suggested more favorable donor-site healing and contour preservation in the LICP-ICBG group, with union between the preserved iliac crest and ilium at 3 months and a decreased defect area at 6 months, whereas the CLCH group showed persistent contour deficiency and, in some cases, a concave deformity. Collectively, these findings suggest that, in patients requiring autologous corticocancellous iliac crest bone grafting for nonunion, minimizing donor-site injury through a modified harvesting technique may help reduce donor-site–related adverse events and improve certain aspects of daily function. Autologous bone grafting remains widely accepted as the gold standard in bone defect reconstruction because of its osteoinductive and osteoconductive properties and its ability to provide osteogenic cells [1]. The iliac crest is one of the most commonly used donor sites due to its accessibility and the relatively abundant supply of cancellous and cortical bone. Nevertheless, donor-site pain, hematoma/seroma, infection, nerve injury, fracture, cosmetic dissatisfaction, and donor-site hernia, although rare, have been consistently reported and remain clinical concerns [1, 10]. Prior studies have reported a wide range of complication rates after iliac crest bone harvesting, likely reflecting differences in patient populations, harvesting techniques, graft volume, outcome definitions, and follow-up duration [11, 12]. Earlier studies suggest that major complications are uncommon, whereas minor-to-moderate complications occur more frequently; technical refinements, such as limiting soft-tissue dissection and performing meticulous layered, tension-free closure, have been proposed to mitigate morbidity [13]. In the present study, the lower overall complication rate observed in the LICP-ICBG group was mainly driven by fewer hematoma/seroma events, fewer nerve-related complications, and fewer contour-related issues, particularly iliac crest depression. This may be attributable to several key steps of the LICP-ICBG technique, including preservation of the lateral iliac crest periosteum, avoidance of extensive lateral dissection, and figure-of-eight fixation of muscle attachments to the preserved lateral iliac crest to reduce dead space—measures that align with general surgical principles for reducing soft-tissue trauma and improving wound stability. In addition, preserving the bony contour and mechanical continuity of the iliac crest may help prevent contour deformity, which is an important component of donor-site cosmetic morbidity. Arrington et al. summarized iliac crest harvesting complications, including fracture, hematoma, infection, and nerve injury, and emphasized that standardizing the technique may reduce their occurrence [10]. Our radiographic findings—better contour maintenance in the LICP-ICBG group and concave deformities in some CLCH cases—are consistent with the intended goal of preserving lateral iliac crest continuity. Notably, the donor-site infection rate was similar between the groups. Donor-site infection has been recognized as a complication after iliac crest bone graft harvesting, although it is generally less frequent than donor-site pain, hematoma/seroma, sensory disturbance, or contour-related morbidity [10, 13]. Arrington et al. reported deep infection as one of the major complications associated with iliac crest bone graft harvesting [10]. Banwart et al. and Seiler et al. also emphasized that infection is an important but relatively uncommon donor-site complication [13, 14]. In a systematic review, Dimitriou et al. reported an overall complication rate of 19.37% after iliac crest bone graft harvesting, with infection included among the reported donor-site morbidities [5]. More recently, Unterfrauner et al. reported a low iliac crest donor-site infection rate of 0.4% in a large retrospective orthopedic cohort, highlighting the variability of reported infection rates across different clinical settings [15]. In our cohort, donor-site infection occurred in 2 patients in the LICP-ICBG group and 2 patients in the CLCH group, suggesting that the modified harvesting technique did not appear to increase infection risk. However, donor-site infection may be influenced by several factors, including patient-related factors, soft-tissue handling, hematoma formation, drainage use, and perioperative antibiotic management. Therefore, the comparable infection rates observed in the present study may indicate that LICP-ICBG has limited influence on infection risk, although a larger sample size and better control of confounding variables would be required to further clarify any potential difference between the two techniques. In addition to surgical technique-related factors, recent clinical studies have emphasized the potential importance of perioperative risk stratification based on inflammatory and nutritional status. Shayimu et al. developed a predictive model for anastomotic leakage after laparoscopic surgery in rectal cancer patients using serum nutritional biomarkers, including prealbumin, albumin, and transferrin, highlighting the association between preoperative nutritional status and postoperative complications [16]. Wang et al. reported that the combined use of the platelet-to-albumin ratio and cancer inflammation prognostic index may provide a simple and accessible approach for prognostic assessment after colorectal cancer surgery [17]. Similarly, Li et al. showed that inflammation-based hematologic markers, including the albumin-to-globulin ratio and neutrophil percentage-to-albumin ratio, were associated with prognosis and could contribute to individualized risk stratification [18]. Although these studies were conducted mainly in gastrointestinal oncologic surgery populations rather than orthopedic bone graft harvesting cohorts, they support the broader concept that baseline inflammatory and nutritional status may influence postoperative recovery and complication risk. In the present study, such markers were not systematically collected or incorporated into the analysis; therefore, residual confounding related to perioperative inflammatory or nutritional status cannot be excluded. We also observed lower intraoperative blood loss in the LICP-ICBG group. Bleeding during iliac crest harvesting may arise from cancellous surfaces and surrounding soft tissues and may be influenced by the extent of subperiosteal dissection, soft-tissue traction, and management of muscle attachments. Reduced lateral dissection, a smaller dissection plane, careful hemostasis, and elimination of dead space may decrease bleeding and subsequent hematoma formation. However, it should be acknowledged that the absolute between-group difference in median blood loss was 23 mL; therefore, the clinical relevance may be limited despite statistical significance. A more balanced interpretation is that LICP-ICBG may facilitate better local tissue handling and bleeding control, but this should be evaluated alongside operative time, graft volume, and perioperative management. Donor-site pain is among the most frequently reported problems after iliac crest harvesting. Prospective studies have suggested that, in some populations, pain may persist and affect activity levels, particularly in spine fusion cohorts [12]. In our study, there were no significant differences in the distribution of pain tolerance on postoperative days 1, 3, and 7, suggesting that acute pain may be comparable between the two techniques. Early postoperative pain is often driven by the combined effects of the incision, periosteal irritation, and local inflammatory responses, which may be difficult to differentiate meaningfully in the immediate postoperative period. In contrast, rising from a seated position depends more heavily on coordinated hip flexion/extension, pelvic stability, and tension balance across the abdominal and perihip musculature, and may therefore be more sensitive to traction-related pain at the donor site. By preserving the lateral iliac crest and minimizing lateral muscle and periosteal dissection, LICP-ICBG may reduce discomfort related to pelvic stability and perihip muscle traction, potentially explaining the observed between-group difference in this functional item. Nevertheless, this remains a biomechanically plausible interpretation and should be validated using objective measures, such as validated lower-extremity functional scores and gait parameters. Regarding nerve-related symptoms, anatomical variations and vulnerability of the lateral femoral cutaneous nerve near the anterior superior iliac spine have been described, and its course may be closely related to incision placement and dissection [19]. Nerve injury occurred only in the CLCH group, which may reflect differences in dissection extent and retraction, although the small sample size warrants cautious interpretation. Cosmetic contour change and local discomfort are key drivers of patient satisfaction. Reviews have suggested that contour-preserving techniques, including “window” approaches, may improve appearance and reduce structural disruption [20]. In our study, LICP-ICBG demonstrated a more intact iliac wing contour on radiographs, a gradual reduction in the defect area over time, and no cases of iliac crest depression, whereas CLCH was associated with contour deficiency and occasional concave deformity. These findings support the concept that preserving the bony scaffold and periosteal continuity may facilitate morphological maintenance and donor-site bone repair. For lean patients or those particularly sensitive to cosmetic outcomes, contour preservation may have greater clinical value. From a clinical perspective, in patients requiring autologous corticocancellous iliac crest bone grafting for tibial shaft, femoral shaft, humeral shaft, or forearm nonunion, our results suggest that, when graft volume requirements allow, prioritizing a contour-preserving approach that minimizes lateral dissection and dead space, such as LICP-ICBG, may reduce the risks of hematoma, nerve-related symptoms, and contour deformity. Regardless of technique, prevention strategies remain essential, including avoiding unnecessary dissection, meticulous hemostasis, layered tension-free closure, and appropriate drainage. This study has several limitations. First, as a retrospective case–control analysis, it is susceptible to selection bias and unmeasured confounding. The choice between LICP-ICBG and CLCH was based on the treating surgeon’s clinical judgment and experience rather than random allocation, which may have introduced treatment-selection bias. Second, several surgical details were not consistently documented in the medical records. Graft volume was not routinely measured during surgery because the harvested bone was directly used for nonunion repair. Drainage use, operative time specifically related to iliac bone harvesting, and other detailed operative variables were also not uniformly recorded; therefore, these factors could not be reliably compared between the groups. Third, pain assessment focused mainly on the early postoperative period, and functional outcomes relied largely on a subjective questionnaire. Radiographic evaluation was limited to routine plain pelvic radiographs and was primarily descriptive. Because no standardized quantitative protocol was used to measure donor-site defect size or contour depression, objective between-group comparisons of radiographic morphology could not be performed. Future prospective studies should standardize graft volume, operative variables, drainage use and management, and analgesic protocols, incorporate objective functional assessments, and use quantitative imaging with longer-term follow-up to comprehensively evaluate the long-term effectiveness and potential benefits of LICP-ICBG. Conclusion In this retrospective study, we compared donor-site outcomes between the LICP-ICBG and CLCH techniques. LICP-ICBG was associated with lower intraoperative blood loss and a reduced overall rate of donor-site complications, with fewer complications, including nerve injury and iliac crest depression. Early postoperative pain did not differ appreciably between the groups; however, patient satisfaction regarding rising from a seated position was higher in the LICP-ICBG group. Radiographic follow-up further suggested that LICP-ICBG better preserved the iliac wing contour and may facilitate donor-site defect repair. Overall, LICP-ICBG appears to provide sufficient autologous corticocancellous iliac crest bone graft material while reducing donor-site morbidity and achieving more favorable morphological outcomes compared with CLCH. Supplementary Information Supplementary Material 1. Acknowledgements Not applicable. Abbreviations Lateral iliac crest–preserving iliac crest bone graft harvesting Conventional iliac crest harvesting Visual analog scale anterior superior iliac spine Authors’ contributions Minhua Hu: Conceptualization; Data curation; Formal analysis; Methodology; Software; Visualization; Writing - original draft; Writing - review & editing. Weifeng Liang: Conceptualization; Data curation; Formal analysis; Methodology; Visualization; Writing - original draft. Feifan luan: Conceptualization; Data curation; Formal analysis; Methodology; Visualization; Writing - original draft. Jiayi Chen: Conceptualization; Data curation; Formal analysis; Methodology; Visualization; Writing - original draft; Chunwei Wei: Conceptualization; Data curation; Formal analysis; Methodology; Software; Visualization; Writing - original draft; Writing - review & editing; ZhiSen Wu: Conceptualization; Data curation; Formal analysis; Visualization; Writing - original draft; Guangwen Yu : Conceptualization; Data curation; Formal analysis; Methodology; Software; Visualization; Writing - original draft; Writing - review & editing. Chenxiao Zheng: Conceptualization; Methodology; Writing - review & editing. Zhuneng Guo: Conceptualization; Methodology; Writing - review & editing. Minhua Hu, Jiayi Chen, Weifeng Liang contributed equally to this work and should be considered co-first authors. All authors contributed to the article and approved the submitted version. Funding This work was supported by University–Hospital Joint Fund Project of Guangzhou University of Chinese Medicine (GZYZS2024G48), GuangDong Basic and Applied Basic Research Foundation (2022B1515230008), Zhongshan Medical Research Project(2024A020337), Research Project of Traditional Chinese Medicine of the Administration of Traditional Chinese Medicine of Guangdong Province(20241025), University–Hospital Joint Fund Project of Guangzhou University of Chinese Medicine (GZYZS2024G44), The Social Public Welfare and Basic Research Project of Zhongshan City(NO.2024B1112). Data availability The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This study was approved by the Institutional Review Board of Zhongshan Hospital of Traditional Chinese Medicine (approval No. 2026ZSZY-LL-KY-051). The requirement for informed consent to participate was waived by the Institutional Review Board of Zhongshan Hospital of Traditional Chinese Medicine because of the retrospective nature of the study and the use of anonymized clinical data. This study was conducted in accordance with the Declaration of Helsinki. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Minhua Hu, Weifeng Liang and Jiayi Chen contributed equally to this work and should be considered co-first authors. Contributor Information Chenxiao Zheng, Email: cuokoo1973@163.com. Zhuneng Guo, Email: 372053279@qq.com. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.